Atlas Trials

Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer

Clinical trial NCT02386709 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02386709
Sponsor
Centre Georges Francois Leclerc
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
FDG PET
Start date
2015-03-25
Primary completion
2028-03-25
Enrollment
275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.